Trial Profile

A phase 2/3 clinical trial of Interferon alpha-2a for the treatment of Covid-19 infection

Status: Planning

Phase of Trial: Phase II/III

Latest Information Update: 04 Jul 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Interferon alpha-2a (Primary)
Indications COVID 2019 infections
Focus Therapeutic Use

Most Recent Events

27 Jun 2022 According to an Amarillo Biosciences media release, the company will begin to prepare the application documents for USA FDA this phase 2/3 clinical trials.
21 Sep 2020 New trial record
10 Sep 2020 According to an Amarillo Biosciences media release, this trial is expected to begin in 2020.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com